Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Projecting future drug expenditures--2004.

James M Hoffman1, Nilay D Shah, Lee C Vermeulen

  • 1Center for Drug Policy and Clinical Economics, University of Wisconsin Hospital and Clinics (UWHC), Madison, WI, USA.

American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|January 31, 2004
PubMed
Summary

Drug expenditure growth moderated in 2002-2003 due to patent expirations and economic factors. Projections indicate continued outpacing of healthcare spending and economic growth.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

National trends in prescription drug expenditures and projections for 2026.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same author

Development of an acuity scoring system to proactively address drug shortages and increase supply chain resiliency.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same author

ASHP and ASHP Foundation Pharmacy Forecast 2026: Strategic Planning Guidance for Pharmacy Departments in Hospitals and Health Systems.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2025
Same author

Key partner priorities for measures of safe outpatient paediatric medication use.

BMJ quality & safety·2025
Same author

Advancing Clinical Pharmacogenomics Worldwide Through the Clinical Pharmacogenetics Implementation Consortium (CPIC).

Clinical pharmacology and therapeutics·2025
Same author

Toward an integrated resource for pharmacogenomics (PGx): Survey findings from the genomic medicine communities.

Genetics in medicine : official journal of the American College of Medical Genetics·2025

Area of Science:

  • Health Economics
  • Pharmaceutical Policy

Background:

  • Drug expenditures have historically shown significant growth.
  • Understanding trends is crucial for healthcare policy and budgeting.

Purpose of the Study:

  • To analyze drug expenditure trends from 2002 onwards.
  • To project future drug expenditures for 2004.

Main Methods:

  • Trend analysis of drug spending data.
  • Review of factors influencing drug expenditures.

Main Results:

  • Drug expenditure growth moderated between 2001-2003 (12.3% in 2002, 10% in H1 2003).
  • Factors include patent expirations, fewer new drug approvals, increased cost-sharing, and economic slowdown.
  • Projected 2004 increases: 10-12% (outpatient), 19-21% (clinics), 6-8% (hospitals).

Related Experiment Videos

Conclusions:

  • Drug spending growth is expected to continue exceeding overall healthcare and economic growth.
  • Moderation factors may be temporary, with potential for renewed acceleration.